Puma Biotechnology (PBYI) Asset Utilization Ratio (2018 - 2026)
Puma Biotechnology (PBYI) reported Asset Utilization Ratio of 1.11 for Q1 2026, down 2.25% on a YoY basis from 1.14 in Q1 2025, and up 1.95% quarter-over-quarter from 1.09 in Q4 2025.
Puma Biotechnology (PBYI) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Puma Biotechnology has reported Asset Utilization Ratio for 9 years, with the latest figure at 1.11 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 2.25% year-over-year to 1.11; the trailing twelve-month figure through Mar 2026 stood at 1.11 (down 2.25% YoY), and the FY2025 full-year result was 1.06, up 2.37% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 1.11, up from 1.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.27 in Q2 2023, with the low at 0.94 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 1.12 across 5 years, with a median of 1.11 in 2022.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 30.8% — and 2024, when it fell 17.71%.
- Puma Biotechnology's Asset Utilization Ratio stood at 1.19 in 2022, then dropped by 8.63% to 1.09 in 2023, then slipped by 2.18% to 1.06 in 2024, then grew by 2.61% to 1.09 in 2025, then climbed by 1.95% to 1.11 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.11 (Q1 2026), 1.09 (Q4 2025), and 1.07 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | 1.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 |
| Dec 31, 2025 | 1.09 |
| Sep 30, 2025 | 1.07 |
| Jun 30, 2025 | 1.22 |
| Mar 31, 2025 | 1.14 |
| Dec 31, 2024 | 1.06 |
| Sep 30, 2024 | 1.14 |
| Jun 30, 2024 | 1.05 |
| Mar 31, 2024 | 1.02 |
| Dec 31, 2023 | 1.09 |
| Sep 30, 2023 | 1.24 |
| Jun 30, 2023 | 1.27 |
| Mar 31, 2023 | 1.23 |
| Dec 31, 2022 | 1.19 |
| Sep 30, 2022 | 1.11 |
| Jun 30, 2022 | 1.05 |
| Mar 31, 2022 | 0.94 |
| Dec 31, 2021 | 1.12 |
| Sep 30, 2021 | 1.03 |
| Jun 30, 2021 | 0.98 |